Completed NA INTERVENTIONAL 2-arm
NCT07338331
Comparative Effects of Aspirin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver Disease (AS-NAFLD)
Comparison Between the Effect of Aspirin and SGLT2 Inhibitor Intake in Non-Alcoholic Fatty Liver on Liver Enzymes, Lipid Profile, and the Results of FibroScan
Sponsor: Galala University
Conditions
Diabete Type 2 Non Alcoholic Fatty Liver
Updated 1 time since 2026 Last updated: Jan 5, 2026 Started: Apr 4, 2023 Primary completion: Apr 5, 2025 Completion: Sep 19, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Diabete Type 2 and Non Alcoholic Fatty Liver, this trial is completed. The trial is conducted by Galala University and has accumulated 1 data snapshot since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Completed — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Galala University
Data source: Galala University
For direct contact, visit the study record on ClinicalTrials.gov .